SLP-2 overexpression is associated with tumour distant metastasis and poor prognosis in pulmonary squamous cell carcinoma

被引:37
作者
Chang, Dong [1 ]
Ma, Kai [1 ]
Gong, Min [1 ]
Cui, Yong [1 ]
Liu, Zhi-hua [2 ,3 ]
Zhou, Xiao-ge [4 ]
Zhou, Chuan-nong [2 ,3 ]
Wang, Tian-you [1 ]
机构
[1] Capital Med Univ, Beijing Friendship Hosp, Dept Thorac Surg, Beijing 100050, Peoples R China
[2] Chinese Acad Med Sci, Canc Inst & Hosp, State Key Lab Mol Oncol, Beijing 100037, Peoples R China
[3] Peking Union Med Coll, Beijing 100021, Peoples R China
[4] Capital Med Univ, Beijing Friendship Hosp, Dept Pathol, Beijing 100050, Peoples R China
关键词
Pulmonary squamous cell carcinoma; SLP-2; tissue micro-array; prognosis; STOMATIN-LIKE PROTEIN-2; CANCER; EXPRESSION; IDENTIFICATION; PROFILE; CLONING; GROWTH; MEMBER; GENES;
D O I
10.3109/13547500903311910
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Objective: To investigate the role of stomatin-like protein 2 (SLP-2), a novel cancer-related gene, in pulmonary squamous cell carcinoma (PSCC) and its implications. Methods: Immunohistochemical detection of SLP-2 was performed on 96 cases of PSCC with a tissue microarray. Results: SLP-2 was overexpressed in lung cancer compared with normal lung tissue (p < 0.001). High-level SLP-2 expression was significantly correlated with distant metastasis (p = 0.025), decreased overall survival (p = 0.018) and disease-free survival (p = 0.017). SLP-2 overexpression was an independent prognostic factor in multivariate analysis using the Cox regression model (p < 0.05). Conclusion: SLP-2 overexpression is associated with tumour distant metastasis and poor prognosis in PSCC. SLP-2 could be regarded as a new significant prognostic biomarker for patients with PSCC.
引用
收藏
页码:104 / 110
页数:7
相关论文
共 20 条
[1]   Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995-99: results of the EUROCARE-4 study [J].
Berrino, Franco ;
De Angelis, Roberta ;
Sant, Milena ;
Rosso, Stefano ;
Lasota, Magdalena B. ;
Coebergh, Jan W. ;
Santaquilani, Mariano .
LANCET ONCOLOGY, 2007, 8 (09) :773-783
[2]   Prognostic significance of stomatin-like protein 2 overexpression in laryngeal squamous cell carcinoma: clinical, histologic, and immunohistochemistry analyses with tissue microarray [J].
Cao, Wen-feng ;
Zhang, Li-yong ;
Liu, Ming-bo ;
Tang, Ping-zhang ;
Liu, Zhi-hua ;
Sun, Bao-cun .
HUMAN PATHOLOGY, 2007, 38 (05) :747-752
[3]   High-level SLP-2 expression and HER-2/neu protein expression are associated with decreased breast cancer patient survival [J].
Cao, Wenfeng ;
Zhang, Bin ;
Liu, Yanxue ;
Li, Hongtao ;
Zhang, Shiwu ;
Fu, Li ;
Niu, Yun ;
Ning, Liansheng ;
Cao, Xuchen ;
Liu, Zhihua ;
Sun, Baocun .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2007, 128 (03) :430-436
[4]   Prognostic significance of PTEN expression in esophageal squamous cell carcinoma from Linzhou City, a high incidence area of northern China [J].
Chang, D. ;
Wang, T.-Y. ;
Li, H.-C. ;
Wei, J.-C. ;
Song, J.-X. .
DISEASES OF THE ESOPHAGUS, 2007, 20 (06) :491-496
[5]  
Cui ZM, 2007, ONCOL REP, V17, P829
[6]  
Gkiozos I, 2007, ANTICANCER RES, V27, P2823
[7]   Cloning and characterization of SLP3: a novel member of the stomatin family expressed by olfactory receptor neurons [J].
Goldstein, BJ ;
Kulaga, HM ;
Reed, RR .
JARO-JOURNAL OF THE ASSOCIATION FOR RESEARCH IN OTOLARYNGOLOGY, 2003, 4 (01) :74-82
[8]   Identification of a novel mitochondrial complex containing mitofusin 2 and stomatin-like protein 2 [J].
Hajek, Petr ;
Chomyn, Anne ;
Attardi, Giuseppe .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (08) :5670-5681
[9]   Lung cancer adjuvant therapy [J].
Horn, Leora ;
Sandler, Alan .
CANCER JOURNAL, 2007, 13 (03) :210-216
[10]  
Lu JY, 2001, INT J CANCER, V91, P288, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1063>3.0.CO